Gavin Gordon, PhD

Gavin joined Akoya in July of 2020 to lead business and market development activities with the goal of establishing Akoya platforms in clinical markets. Prior to Akoya, Gavin was VP, Commercial Operations at Fluidigm, where he held multiple global roles including establishing pharma strategic alliances and developing the translational research market for high parameter immunohistochemistry. Gavin was also the commercial lead for the IUO phase of Thermo Fisher’s NGS-based universal companion diagnostic for cancer therapy selection. Prior to joining industry, Gavin was an Assistant Professor at Harvard Medical School and faculty member at Brigham and Women’s Hospital and Dana Farber/Harvard Cancer Center. Gavin received PhD in Molecular Pathology from UNC Chapel Hill and his MBA from Babson College.